| Literature DB >> 29915239 |
Lemlem Weldegerima Gebremariam1, Chifa Chiang1, Hiroshi Yatsuya1,2, Esayas Haregot Hilawe1,3, Alemayehu Bayray Kahsay4, Hagos Godefay5, Loko Abraham4,6, Yoshihisa Hirakawa1, Hiroyasu Iso7, Atsuko Aoyama8.
Abstract
The burden of non-communicable diseases (NCDs) is increasing in Ethiopia. This study aims to describe the prevalence of NCD risk factors of public employees in a regional city in northern Ethiopia. We conducted a cross-sectional epidemiological study targeting men and women aged 25-64 years employed by public offices in Mekelle. The prevalence was age-standardized to the Ethiopian 2007 population. Among the 1380 subjects (823 men and 557 women), 68.7% had less than 1 serving of fruits and vegetables per day, 41.0% were physically inactive, and 57.3% observed religious fast. The age-standardised prevalence of abdominal obesity was 29.3% in men and 58.5% in women, but that of metabolic syndrome was comparable between men (39.2%) and women (39.0%). The prevalence of diabetes was underestimated if only fasting blood glucose (FBG) was used for the diagnosis compared to combination of FBG and glycated haemoglobin (HbA1c) (6.7% in men and 3.8% in women vs. 12.1% in men and 5.6% in women). More than a quarter (26.1%) of men and 8.7% of women had estimated 10-year risk of cardiovascular disease of 10% or more. This study revealed the high prevalence of NCD metabolic risk factors among the urban public employees in the highland of Ethiopia.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29915239 PMCID: PMC6006379 DOI: 10.1038/s41598-018-27519-6
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Demographic and behavioural characteristics of participants by gender.
| Characteristics | Men | Women | All |
|
|---|---|---|---|---|
| Number | 823 | 557 | 1380 | |
| Age, years | 0.040 | |||
| 25–34 | 33.2% | 39.1% | 35.6% | |
| 35–44 | 34.4% | 34.8% | 34.6% | |
| 45–54 | 23.8% | 18.3% | 21.6% | |
| 55–64 | 8.6% | 7.7% | 8.3% | |
| mean (95% CI)b | 40.3 (39.6–40.9) | 38.3 (37.6–39.1) | 39.5 (39.0–40.0) | <0.001 |
| Marital status | <0.001 | |||
| Never married | 25.2% | 23.5% | 24.5% | |
| Currently married | 70.8% | 59.6% | 66.3% | |
| Separated/divorced/widowed | 4.0% | 16.9% | 9.2% | |
| Formal education, years | ||||
| ≤8 | 5.7% | 7.1% | 6.3% | 0.249 |
| 9–12 | 12.5% | 10.1% | 11.5% | |
| >12 | 81.9% | 82.8% | 82.2% | |
| Annual income, USD per adult | <0.001 | |||
| <500 | 21.0% | 31.9% | 25.4% | |
| 500–1000 | 28.3% | 29.9% | 28.9% | |
| 1001–1500 | 21.7% | 17.5% | 20.0% | |
| >1500 | 29.0% | 20.7% | 25.7% | |
| median (IQR) | 1142 (1143) | 1001 (1001) | 990 (1025) | <0.001 |
| Religion | 0.459 | |||
| Ethiopian Orthodox Christian | 95.6% | 95.1% | 95.4% | |
| Muslim | 2.9% | 2.5% | 2.8% | |
| Other Christian | 1.5% | 2.3% | 1.8% | |
| Fasting practice, length of fasting on a fast day | <0.001 | |||
| None | 52.5% | 28.5% | 42.8% | |
| <6 hours | 9.3% | 5.2% | 7.7% | |
| ≥6 hours | 38.2% | 66.3% | 49.6% | |
| Fruit/vegetable intake, servings per day | <0.001 | |||
| <1 | 71.9% | 63.9% | 68.7% | |
| 1–2.9 | 23.8% | 30.9% | 26.6% | |
| 3–4.9 | 3.9% | 5.0% | 4.4% | |
| ≥5.0 | 0.4% | 0.2% | 0.3% | |
| Tobacco smoking | <0.001 | |||
| non-smoker | 91.0% | 98.9% | 94.2% | |
| ex-smoker | 5.7% | 0.6% | 3.6% | |
| current smoker | 3.3% | 0.5% | 2.2% | |
| <0.001 | ||||
| non-chewer | 90.7% | 99.1% | 94.1% | |
| ex-chewer | 6.7% | 0.7% | 4.3% | |
| current chewer | 2.6% | 0.2% | 1.6% | |
| Alcohol drinking, days per week | <0.001 | |||
| <1 day per month | 23.6% | 73.9% | 42.9% | |
| 1–3 days per month | 28.3% | 20.3% | 25.2% | |
| 1–2 days per week | 32.1% | 4.7% | 21.6% | |
| ≥3 days per week | 15.9% | 1.1% | 10.2% | |
| Alcohol drinking, standard drinks per day | <0.001 | |||
| <1 | 72.2% | 97.7% | 81.1% | |
| 1–2.9 | 23.5% | 2.3% | 16.1% | |
| 3–3.9 | 3.1% | 0.0% | 2.0% | |
| ≥4.0 | 1.2% | 0.0% | 0.8% | |
| Physical activity, MET-minutes per week | <0.001 | |||
| <600 | 34.0% | 51.4% | 41.0% | |
| 600–2999 | 52.1% | 37.5% | 46.2% | |
| ≥3000 | 13.9% | 11.2% | 12.8% | |
Abbreviations: CI, confidence interval; USD, United States dollar; IQR, Interquartile range; MET, metabolic equivalent.
aDifferences between all men and all women were tested with a chi-squared test and t-test as appropriate.
b95% CI of the mean.
cAnnual household income divided by number of household members ≥18 years. (1 USD ≈ 21 Ethiopian Birr).
Physical and biochemical characteristics of participants by gender.
| Characteristics | Men | Women | All | |
|---|---|---|---|---|
| Number | 823 | 557 | 1380 | |
| Body mass index, kg/m2 | 0.001 | |||
| <18.5 | 10.6% | 15.3% | 12.5% | |
| 18.5–24.9 | 61.2% | 51.9% | 57.5% | |
| 25.0–29.9 | 25.1% | 27.2% | 26.0% | |
| ≥30.0 | 3.1% | 5.6% | 4.1% | |
| mean (95% CI) | 23.2 (14.8–31.6) | 23.1 (13.9–32.4) | 23.2 (14.4–31.9) | 0.623 |
| Waist circumference, cm | <0.001 | |||
| ≤80 | 21.4% | 40.3% | 29.0% | |
| 81–90 | 34.0% | 26.0% | 30.8% | |
| 91–94 | 13.6% | 12.2% | 13.0% | |
| >94 | 31.1% | 21.6% | 27.2% | |
| mean (95% CI) | 89.0 (68.6–109.3) | 84.3 (59.9–108.7) | 87.1 (64.4–109.6) | <0.001 |
| Waist-hip ratio | <0.001 | |||
| <0.80 | 7.1% | 28.3% | 17.4% | |
| 0.80–0.84 | 15.6% | 22.9% | 18.5% | |
| 0.85–0.89 | 26.4% | 23.6% | 25.3% | |
| ≥0.90 | 50.9% | 25.2% | 40.5% | |
| mean (95% CI) | 0.90 (0.75–1.06) | 0.85 (0.68–1.02) | 0.88 (0.71–1.05) | <0.001 |
| Systolic blood pressure, mmHg | <0.001 | |||
| <120 | 44.8% | 69.7% | 54.9% | |
| 120–129 | 27.1% | 16.0% | 22.6% | |
| 130–139 | 15.9% | 6.3% | 12.0% | |
| ≥140 | 12.2% | 8.1% | 10.5% | |
| mean (95% CI) | 123 (92–154) | 114 (82–147) | 119 (87–152) | <0.001 |
| Diastolic blood pressure, mmHg | <0.001 | |||
| <80 | 44.2% | 63.7% | 52.1% | |
| 80–84 | 21.8% | 15.4% | 19.2% | |
| 85–89 | 16.6% | 10.2% | 14.0% | |
| ≥90 | 17.4% | 10.6% | 14.7% | |
| mean (95% CI) | 81 (62–101) | 77(59–96) | 80 (60–99) | <0.001 |
| Fasting blood glucose, mg/dL | <0.001 | |||
| <100 | 74.7% | 89.2% | 80.6% | |
| 100–125 | 18.6% | 7.0% | 13.9% | |
| ≥126 | 6.7% | 3.8% | 5.5% | |
| mean (95% CI)b | 96 (93–98) | 88 (86–91) | 93 (90–95) | <0.001 |
| HbA1c, % | <0.001 | |||
| <5.7 | 55.6% | 64.3% | 59.1% | |
| 5.7–6.4 | 32.3% | 30.1% | 31.4% | |
| ≥6.5 | 12.1% | 5.6% | 9.5% | |
| mean (95% CI)b | 5.8 (3.5–8.1) | 5.6 (3.4–7.8) | 5.7 (3.4–8.0) | 0.031 |
| Total cholesterol, mg/dL | 0.596 | |||
| <150 | 25.2% | 23.4% | 24.5% | |
| 150–189 | 42.8% | 44.8% | 43.6% | |
| 190–199 | 6.5% | 7.0% | 6.7% | |
| 200–239 | 18.5% | 19.4% | 18.9% | |
| ≥240 | 7.0% | 5.4% | 6.3% | |
| mean (95% CI) | 176 (99–254) | 176 (102–250) | 176 (100–252) | 0.932 |
| HDL cholesterol, mg/dL | <0.001 | |||
| <40 | 70.1% | 41.6% | 59.2% | |
| 40–49 | 21.0% | 32.5% | 25.4% | |
| ≥50 | 8.8% | 25.9% | 15.3% | |
| mean (95% CI)b | 34 (32–37) | 41(39–44) | 37 (34–39) | <0.001 |
| LDL cholesterol, mg/dL | <0.001 | |||
| <100 | 43.1% | 57.7% | 48.4% | |
| 100–129 | 35.2% | 25.2% | 31.6% | |
| 130–159 | 15.8% | 13.4% | 15.0% | |
| ≥160 | 5.8% | 3.6% | 5.0% | |
| mean (95% CI) | 107 (44–170) | 96 (26–167) | 103 (37–170) | <0.001 |
| Triglycerides, mg/dL | <0.001 | |||
| <100 | 20.2% | 14.3% | 17.9% | |
| 100–149 | 29.3% | 21.8% | 26.4% | |
| 150–199 | 18.8% | 17.8% | 18.4% | |
| ≥200 | 31.7% | 46.1% | 37.3% | |
| mean (95% CI)b | 154 (151–158) | 191 (187–195) | 168 (164–171) | <0.001 |
| Haemoglobin, mg/dL | <0.001 | |||
| <11.0 | 0.2% | 0.4% | 0.3% | |
| 11.0–11.9 | 0.2% | 1.8% | 0.9% | |
| 12.0–12.9 | 0.9% | 5.4% | 2.7% | |
| 13.0–16.9 | 53.6% | 89.6% | 68.1% | |
| ≥17.0 | 45.1% | 2.9% | 28.0% | |
| mean (95% CI) | 16.7 (14.0–19.5) | 14.6 (12.2–17.1) | 15.9 (12.5–19.2) | <0.001 |
Abbreviations: CI, confidence interval; HbA1c, glycated haemoglobin; HDL, high-density lipoprotein; LDL, low-density lipoprotein.
aDifferences between all men and all women were tested with a chi-squared test or t-test as appropriate.
bLog-transformed data were used.
Prevalence and age-standardised prevalence of non-communicable disease risk factors by gender (%).
| Risk factors | Prevalence (95% CI) | Age-standardised prevalencea (95% CI) | ||||||
|---|---|---|---|---|---|---|---|---|
| Men | Women | All |
| Men | Women | All |
| |
| Overweight/obesity | ||||||||
| BMI ≥25 kg/m2 | 28.2 | 32.8 | 30.1 | 0.720 | 26.9 | 31.5 | 28.5 | 0.008 |
| BMI ≥30 kg/m2 | 3.1 | 5.6 | 4.1 | 0.025 | 2.9 | 5.4 | 3.9 | 0.008 |
| Increased waist circumference | 31.1 | 59.8 | 42.7 | <0.001 | 29.3 | 58.5 | 40.1 | <0.001 |
| Increased waist-hip ratio | 50.9 | 48.8 | 50.0 | 0.460 | 47.7 | 47.9 | 47.7 | 0.512 |
| Hypertension | 22.5 | 15.3 | 19.6 | 0.001 | 22.4 | 15.3 | 19.4 | 0.017 |
| Diabetes | ||||||||
| Fasting blood glucose ≥126 mg/dL or on treatment | 7.9 | 4.1 | 6.4 | 0.005 | 7.2 | 4.1 | 6.0 | <0.001 |
| HbA1c ≥6.5% or on treatment | 12.5 | 5.6 | 9.7 | <0.001 | 11.4 | 5.6 | 9.2 | <0.001 |
| Fasting blood glucose ≥126 mg/dL or | 13.0 | 5.9 | 10.1 | <0.001 | 12.1 | 5.9 | 9.7 | |
| Raised total cholesterol | 32.0 | 31.8 | 31.9 | 0.953 | 30.4 | 30.6 | 30.3 | 0.354 |
| Low HDL cholesterol | 70.1 | 74.1 | 71.6 | 0.118 | 69.9 | 73.8 | 71.3 | 0.097 |
| Raised LDL cholesterol | 21.6 | 17.0 | 20.0 | 0.520 | 20.8 | 16.0 | 18.9 | 0.145 |
| Raised triglycerides | 50.5 | 63.9 | 55.7 | <0.001 | 48.7 | 63.2 | 54.5 | <0.001 |
| Metabolic syndromec | 41.1 | 40.2 | 40.7 | 0.751 | 39.2 | 39.0 | 39.0 | 0.476 |
| Framingham risk scored | 22.3 | 7.0 | 16.5 | <0.001 | 26.1 | 8.7 | 19.6 | <0.001 |
Abbreviations: BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; HbA1c, glycated haemoglobin; HDL, high-density lipoprotein; LDL, low-density lipoprotein.
aAge-standardized prevalence was calculated by direct standardization method using the Ethiopian 2007 population and housing census as a standard population.
bDifferences between all men and all women were tested with a chi-squared test.
cMinimum of three of the following criteria: SBP/DBP ≥130/85 mmHg or on medication; fasting blood glucose ≥100 mg/dL or on treatment; triglycerides ≥150 mg/dL or on medication; HDL cholesterol <40 mg/dL for men and <50 mg/dL for women; waist circumference ≥94 cm for men and ≥80 cm for women.
d10-year cardiovascular disease risk prediction for the age 30 years old and more based on the Framingham cardiovascular disease risk prediction point score method.
Figure 1Scatter plot of fasting blood glucose (FBG) and glycated haemoglobin (HbA1c) values. Four quadrants divided by cut-off lines, FBG ≥126 mg/dL and HbA1c ≥6.5%, for detecting diabetes display the interrater agreement and disagreement of the detection by these two methods.
Prevalence of non-communicable disease risk factors among religious fast-observers and non-fast-observers (%).
| Men | Women | All | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Fast-observer | Non-fast-observer |
| Fast-observer | Non-fast-observer |
| Fast-observer | Non-fast-observer |
| |
| N | 377 | 438 | 394 | 161 | 771 | 599 | |||
| Body mass index, kg/m2 | 0.047 | 0.313 | 0.081 | ||||||
| <18.5 | 13.3 | 8.0 | 15.0 | 16.3 | 14.2 | 10.3 | |||
| 18.5–24.9 | 61.6 | 60.9 | 50.4 | 55.6 | 55.9 | 59.5 | |||
| 25.0–29.9 | 22.4 | 27.6 | 28.0 | 25.0 | 25.3 | 26.9 | |||
| ≥30.0 | 2.7 | 3.4 | 6.6 | 3.1 | 4.7 | 3.4 | |||
| Increased waist circumference | 31.8 | 36.2 | 0.186 | 62.8 | 58.5 | 0.344 | 47.6 | 42.2 | 0.045 |
| Increased waist-hip ratio | 48.0 | 53.6 | 0.140 | 50.0 | 45.9 | 0.385 | 49.0 | 51.5 | 0.361 |
| Hypertensiona | 21.8 | 23.3 | 0.601 | 15.7 | 14.3 | 0.667 | 18.7 | 20.9 | 0.311 |
| Diabetesb | 9.3 | 16.2 | 0.003 | 6.3 | 5.0 | 0.534 | 7.8 | 13.2 | 0.001 |
| Fasting blood glucose ≥126 mg/dL | 4.5 | 8.8 | 0.006 | 3.8 | 3.7 | 0.285 | 4.2 | 7.4 | 0.001 |
| HbA1c ≥6.5% | 8.5 | 15.2 | 0.001 | 5.8 | 5.0 | 0.658 | 7.1 | 12.5 | 0.001 |
| Low HDL cholesterol | 67.3 | 72.2 | 0.130 | 72.4 | 78.9 | 0.135 | 69.8 | 73.9 | 0.103 |
| Raised LDL cholesterol ≥130 mg/dL | 18.6 | 24.4 | 0.055 | 16.9 | 17.7 | 0.829 | 17.8 | 22.8 | 0.030 |
| Raised triglycerides ≥150 mg/dL | 44.1 | 55.7 | 0.001 | 64.3 | 63.2 | 0.808 | 50.4 | 57.6 | 0.198 |
Abbreviations: HDL, high-density lipoprotein; LDL, low-density lipoprotein; HbA1c, glycated haemoglobin.
aSystolic blood pressure/diastolic blood pressure ≥140/90 mmHg or on medication.
bFasting blood glucose ≥ 126 mg/dL or HbA1c ≥6.5% or on treatment.